| Nome |
# |
|
100 Years of Drug Delivery to the Lungs, file e398c37f-09bc-179a-e053-3705fe0a4cff
|
11.631
|
|
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes, file e398c37d-9f3d-179a-e053-3705fe0a4cff
|
1.425
|
|
The lung microbiome: clinical and therapeutic implications, file e398c37f-4e23-179a-e053-3705fe0a4cff
|
1.181
|
|
The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis, file e398c37d-9f38-179a-e053-3705fe0a4cff
|
1.021
|
|
Concomitant Bilastine and Montelukast as Additive Therapy for Seasonal Allergic Rhinoconjunctivits and Mild-to-Moderate Asthma. The SKY Study, file e398c37e-947a-179a-e053-3705fe0a4cff
|
825
|
|
Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here?, file e398c37d-909f-179a-e053-3705fe0a4cff
|
762
|
|
Dilemmas, Confusion, and Misconceptions Related to Small Airways Directed Therapy, file e398c37f-1d39-179a-e053-3705fe0a4cff
|
597
|
|
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR), file e398c37f-0968-179a-e053-3705fe0a4cff
|
487
|
|
Effect of an anti-reflux medical device in the control of deflation cough: A placebo-controlled comparative study with an antacid drug in chronic coughers, file e398c37b-294e-179a-e053-3705fe0a4cff
|
428
|
|
A Randomized Clinical Trial Comparing the Effects of Antitussive Agents on Respiratory Center Output in Patients With Chronic Cough., file e398c37c-7bc7-179a-e053-3705fe0a4cff
|
398
|
|
Antitussive effect of carcainium chloride in patients with chronic cough and idiopathic interstitial pneumonias: A pilot study, file e398c37b-2ada-179a-e053-3705fe0a4cff
|
368
|
|
The demographic and clinical characteristics of an Italian population of adult outpatients with chronic cough, file e398c380-9149-179a-e053-3705fe0a4cff
|
250
|
|
A 57-year-old chronic cougher with somatically evoked cough., file e398c37c-7d49-179a-e053-3705fe0a4cff
|
220
|
|
Cough and ventilatory adjustments evoked by aerosolised capsaicin and distilled water (fog) in man, file e398c37b-f178-179a-e053-3705fe0a4cff
|
212
|
|
Desensitization of the cough reflex by exercise and voluntary isocapnic hyperpnea, file e398c37e-63f5-179a-e053-3705fe0a4cff
|
201
|
|
Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy, file e398c37d-82cc-179a-e053-3705fe0a4cff
|
198
|
|
Successful Use of Easyhaler® Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical Trials, file 15b0a5dc-1c45-45df-9d2e-fb23ac51eb2d
|
194
|
|
What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape, file e398c37f-13e0-179a-e053-3705fe0a4cff
|
181
|
|
Understanding the importance of capsules in dry powder inhalers, file e398c381-e52e-179a-e053-3705fe0a4cff
|
178
|
|
Retail sales of inhalation devices in European countries: So much for a global policy, file e398c37e-63f7-179a-e053-3705fe0a4cff
|
177
|
|
Increased Risk of Atherosclerosis in Patients with Sarcoidosis, file e398c37c-ccc2-179a-e053-3705fe0a4cff
|
167
|
|
Critical inhaler errors in asthma and COPD: A systematic review of impact on health outcomes, file e398c37d-cbea-179a-e053-3705fe0a4cff
|
146
|
|
What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis, file e398c37e-ffe0-179a-e053-3705fe0a4cff
|
136
|
|
Inhaler technique: Facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT), file e398c37c-a5a6-179a-e053-3705fe0a4cff
|
135
|
|
Trace metals in fluids lining the respiratory system of patients with idiopathic pulmonary fibrosis and diffuse lung diseases, file e398c37d-dcc1-179a-e053-3705fe0a4cff
|
130
|
|
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD, file e398c37d-6887-179a-e053-3705fe0a4cff
|
128
|
|
Inhaler technique mastery and maintenance in healthcare professionals trained on different devices, file e398c37d-6d2c-179a-e053-3705fe0a4cff
|
128
|
|
Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD, file e398c37e-5521-179a-e053-3705fe0a4cff
|
127
|
|
The dry powder inhaler features of the Easyhaler that benefit the management of patients, file e398c380-b141-179a-e053-3705fe0a4cff
|
127
|
|
Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: The Easy Low Instruction Over Time (ELIOT) study, file e398c37d-909a-179a-e053-3705fe0a4cff
|
124
|
|
Gorham-Stout Disease Management during Pregnancy, file e398c37c-9e0b-179a-e053-3705fe0a4cff
|
123
|
|
Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease, file e398c37e-68b8-179a-e053-3705fe0a4cff
|
122
|
|
Recent advances in capsule-based dry powder inhaler technology, file e398c37c-8901-179a-e053-3705fe0a4cff
|
120
|
|
A multinational observational study identifying primary care patients at risk of overestimation of asthma control, file e398c37f-352f-179a-e053-3705fe0a4cff
|
114
|
|
Clinical courses and outcomes of five patients with primary lung cancer surgically treated while affected by Severe acute respiratory syndrome coronavirus 2, file e398c380-328f-179a-e053-3705fe0a4cff
|
113
|
|
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study, file e398c381-5e01-179a-e053-3705fe0a4cff
|
109
|
|
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting, file e398c37f-0964-179a-e053-3705fe0a4cff
|
103
|
|
The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes, file e398c37f-2d4d-179a-e053-3705fe0a4cff
|
103
|
|
Diagnosis and treatment of pulmonary embolism: a multidisciplinary approach., file e398c37a-7d2d-179a-e053-3705fe0a4cff
|
100
|
|
Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series, file e398c380-5f7a-179a-e053-3705fe0a4cff
|
99
|
|
Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes, file e398c37f-5a3e-179a-e053-3705fe0a4cff
|
86
|
|
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: A retrospective matched observational study of real-world patients, file e398c37f-3539-179a-e053-3705fe0a4cff
|
82
|
|
Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: A randomised, crossover, open-label study, file e398c37f-1d3d-179a-e053-3705fe0a4cff
|
80
|
|
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study, file e398c380-431b-179a-e053-3705fe0a4cff
|
79
|
|
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN), file e398c37f-5c18-179a-e053-3705fe0a4cff
|
78
|
|
Correct inhalation technique is critical in achieving good asthma control, file e398c37f-5c14-179a-e053-3705fe0a4cff
|
77
|
|
The challenge of delivering therapeutic aerosols to asthma patients, file e398c37e-ede4-179a-e053-3705fe0a4cff
|
76
|
|
Validation of a method to assess emphysema severity by spirometry in the COPDGene study., file e398c37f-b0f0-179a-e053-3705fe0a4cff
|
76
|
|
Pulmonary hypertension nosography: are all patients classifiable?, file e398c37c-de09-179a-e053-3705fe0a4cff
|
75
|
|
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN), file e398c37f-3531-179a-e053-3705fe0a4cff
|
75
|
|
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab, file e398c381-8820-179a-e053-3705fe0a4cff
|
75
|
|
Patients’ perspectives and preferences in the choice of inhalers: The case for Respimat® or HandiHaler®, file e398c37f-1d36-179a-e053-3705fe0a4cff
|
69
|
|
Switching treatments in COPD: Implications for costs and treatment adherence, file e398c37f-1d3f-179a-e053-3705fe0a4cff
|
69
|
|
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD, file e398c380-84c7-179a-e053-3705fe0a4cff
|
57
|
|
The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care Patients, file e398c380-a2ff-179a-e053-3705fe0a4cff
|
54
|
|
Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes, file 5e309f9b-1da0-4e56-873a-2a448d9de093
|
48
|
|
Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic, file e398c381-7104-179a-e053-3705fe0a4cff
|
47
|
|
Why We Should Target Small Airways Disease in Our Management of Chronic Obstructive Pulmonary Disease, file e398c381-8796-179a-e053-3705fe0a4cff
|
43
|
|
Somatic points for cough and urge to cough in chronic coughers, file 3f54f8b6-fb6e-428c-b77a-0e013d2e1bc0
|
42
|
|
Switching to the Dry-Powder Inhaler Easyhaler®: A Narrative Review of the Evidence, file e398c381-9a79-179a-e053-3705fe0a4cff
|
41
|
|
Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study), file e398c381-d797-179a-e053-3705fe0a4cff
|
38
|
|
MYCROWAVE ABLATION OF CENTRAL AIRWAY STENOSES, file e398c381-5a4f-179a-e053-3705fe0a4cff
|
17
|
|
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19, file 6918a280-a259-42d4-9e50-c56a501c3a58
|
14
|
|
Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs, file 3d74c4b7-77be-4703-b562-2ed532432201
|
10
|
|
Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study, file a320109d-a880-4184-85d2-d7600182aecb
|
10
|
|
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent, file e398c380-d40c-179a-e053-3705fe0a4cff
|
10
|
|
Recent advances in capsule-based dry powder inhaler technology, file e398c37d-fefd-179a-e053-3705fe0a4cff
|
9
|
|
Microbiota and IPF: hidden and detected relationships, file e398c382-02a3-179a-e053-3705fe0a4cff
|
9
|
|
Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers, file 068f3f1c-bbae-4716-b4f7-6ef0e2fdd0f2
|
8
|
|
A Randomized Clinical Trial Comparing the Effects of Antitussive Agents on Respiratory Center Output in Patients With Chronic Cough., file e398c37e-97e5-179a-e053-3705fe0a4cff
|
8
|
|
Clinical recommendations for dry powder inhaler use in the management of COPD in primary care, file 750ec590-4f66-4539-89b0-0900c0ea6df9
|
7
|
|
Somatically evoked cough responses help to identify patients with difficult-to-treat chronic cough: a six-month observational cohort study, file ab806cec-2ea2-46f3-9e21-a89b2326ab73
|
7
|
|
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection, file 4620e128-7e78-4a70-a9a2-1f1c1e0c7926
|
4
|
|
Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes, file 47cae579-e8fb-400e-8fb2-9a5024a5738e
|
2
|
|
Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study, file 494c5e1d-3311-4173-9818-9a8bc38031b3
|
2
|
|
The Clinical Value of Deflation Cough in Chronic Coughers with Reflux Symptoms, file e398c37b-20fc-179a-e053-3705fe0a4cff
|
2
|
|
Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium, file 1419fc3c-1d5b-4477-ad83-ed3b8a335ce4
|
1
|
|
“Adrenaline junkie”: a case report of repeated use of epinephrine, file a9848404-56ee-4701-a690-3442d0e20449
|
1
|
|
Somatically evoked cough responses help to identify patients with difficult-to-treat chronic cough: a six-month observational cohort study, file b670702b-cb8c-46ab-aa8d-e8b674e5967c
|
1
|
|
Inhaler choice and inhalation technique: key factors for asthma control., file e398c378-8299-179a-e053-3705fe0a4cff
|
1
|
|
Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD., file e398c378-bafd-179a-e053-3705fe0a4cff
|
1
|
|
Trace metals in fluids lining the respiratory system of patients with idiopathic pulmonary fibrosis and diffuse lung diseases, file e398c37c-f037-179a-e053-3705fe0a4cff
|
1
|
| Totale |
24.880 |